Chemist Warehouse feels like a simple retail story until you look at the structure behind it and the way it’s entered the sharemarket through Sigma. We walk through what Sigma actually does, why most of us haven’t heard of it, and how a “merger” can effectively operate as a reverse takeover when a much larger private business takes centre stage. If you’ve been watching the headlines and wondering why a company with no obvious need for cash would list at all, we unpack the motivations: liquidity for long time owners, the signalling value of being publicly listed, and the credibility that comes with transparent reporting when you’re talking to governments and regulators. 

From there we dig into the engine room: the franchise style model, the buying power, and why not owning every property can keep debt low while still scaling fast. We talk about what makes Chemist Warehouse attractive to investors, including dependable demand drivers like an ageing population, plus the less obvious detail that a large share of sales comes from front of store products rather than prescriptions. We also keep it grounded with the big caution flag: price. A great business can still be a risky investment if the valuation has already “galloped away”, and offshore growth plans are never guaranteed. 

Then we open the phones and tackle the questions people are really making decisions on right now: gifting shares to adult grandchildren and the tax traps to watch, whether superannuation should keep lifting exposure to international shares even when the US feels politically unstable, and what to do after receiving a small inheritance that could clear the mortgage. We also cover bonds, interest rate expectations, franking credits for retirees, and a pointed warning about how debt can unravel even big names like Mineral Resources. If you value practical investing talk that connects markets to everyday choices, subscribe, share this with a mate, and leave us a review telling us what topic you want next.

Send us Fan Mail

Support the show